Patent Daily RSS
June 2017 M T W T F S S « Nov 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Twitter Guna
- RT @digvijaya_28: Political turmoil in TN and Governor playing truant. Is he fulfilling his duties ? No. He is doing politics under directi… 4 months ago
- RT @VikasDandekarET: #Cipla bets on speciality #pharma business in US; aims for commercial launches by 2020 economictimes.indiatimes.com/industry/healt… 1 year ago
- RT @scarthik: @itisprashanth வாழ்வில் நமதுதேவை குறித்த தெளிவான தேர்வும், அதைநோக்கிய நேர்மையான தேடலும்இருந்துவிட்டால், வெற்றி கூடிவரும். அமை… 1 year ago
- VPATAPP – A mobile application for patent professionals in Android platform patentdaily.wordpress.com/2015/11/22/vpa… https://t.co/JzoiBsY2XB 1 year ago
- Guest Post: The Delhi High Court has its Hands Tied: Writ Concerning Divisional Patent Applications spicyip.com/2015/07/guest-… via @spicyip 1 year ago
- Delhi High Court upholds BMS’ patent for cancer drug Dasatinib bit.ly/1NM4hi0 1 year ago
- Delhi HC resumes trial in Glenmark-Merck Sharp and Dohme patent case - Livemint livemint.com/Companies/FhAO… 1 year ago
- Need to bring our patent laws on par with global standards: Narendra Modi bit.ly/1HtQCMw 2 years ago
- SC stays Delhi HC order restraining Glenmark from making anti-diabetes drug - Livemint livemint.com/Companies/H0Tj… 2 years ago
- Glenmark can't sell diabetes drug Zita, Zita-Met bit.ly/1xapjmN 2 years ago
Tag Archives: Intas
Madras High Court – Erlotinib patent infringement suits
[Business Line] [India Infoline] [Order] We are aware that Roche has filed patent infringement suit against some companies (Intas, Matrix) in Madras High Court which is related to Erlotinib and the patent No. 196774. Both of the suits and connected … Continue reading
Posted in Daily interesting IP news, Patent case
Tagged 196774, Erlotinib, Intas, Matrix, Roche
Leave a comment
